• Intranet
DARE-NL
  • About
    • DARE-NL
    • What are ATMPs (ENG)
    • More information
    • Wat zijn ATMPs (NL)
    • Meer weten?
  • Activities
    • Workpackage 1
    • Workpackage 2
    • Workpackage 3
    • Workpackage 4
    • Workpackage 5
    • Workpackage 6
    • Workpackage 7
  • People and Partners
    • Organisation
    • Supporting organisations
    • Management Team
    • Project Team
    • Steering Committee
    • Patient Advisory Board
    • Patient Participation Review Committee
    • Scientific Advisory Board
    • Vacancies
  • Courses & Events
    • Course directory
    • Submit new course
    • External course directories
    • Master courses
    • Upcoming events
    • Past events
    • Annual meeting
      • Annual meeting 2025
      • Annual meeting 2024
        • Program
        • Sponsors
        • Pictures
      • Annual meeting 2023
        • Program
        • Sponsors
        • Pictures
  • Resources
    • Tools
      • ATMP & Regenerative medicine
      • Regulations
      • Costs and lead times
      • Clinical trials
    • Publications
      • All publications
      • News items
      • Scientific articles
    • Newsletters
    • Links
  • Get in touch
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

DARE-NL Workshop: Regulatory Sciences, HTA & ATMP-NL

Uncategorized
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2025-02-03 12:36:102025-03-21 13:29:46DARE-NL Workshop: Regulatory Sciences, HTA & ATMP-NL

ATMP operator workshop

Uncategorized
2025-02-03
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2025-02-03 10:58:322025-03-31 10:26:48ATMP operator workshop

CTGCT webinar by UCL experts: Introduction to IP and commercialisation

Uncategorized
2025-02-03
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2025-01-24 11:59:132025-01-24 11:59:35CTGCT webinar by UCL experts: Introduction to IP and commercialisation

Annual consortium meeting

Uncategorized
2024-09-27
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2024-09-27 12:37:202025-03-12 15:49:51Annual consortium meeting

Is the proposed EU General Pharmaceutical Legislation ready to support pharmaceutical innovation?

News items, Uncategorized
2024-09-27
https://www.dare-nl.nl/wp-content/uploads/2024/07/VWS-rapport-3.jpg 766 799 Simone Punt https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Simone Punt2024-04-30 12:00:482024-08-28 12:10:29Is the proposed EU General Pharmaceutical Legislation ready to support pharmaceutical innovation?

Newsletter March 2024

Newsletters, Uncategorized
2024-09-27
https://www.dare-nl.nl/wp-content/uploads/2023/03/newsletter01-hd.jpg 1080 1440 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2024-03-13 11:01:392024-03-13 11:08:36Newsletter March 2024

Program 2024

Uncategorized
2024-02-26
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2024-02-26 09:53:522024-09-16 09:02:09Program 2024

Article in BJCP: ‘EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells’

Scientific articles, Uncategorized
2024-02-26
https://www.dare-nl.nl/wp-content/uploads/2024/04/BJCP.png 602 806 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2024-02-15 09:54:152024-07-02 09:27:25Article in BJCP: ‘EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells’

Pictures annual meeting 2023

Uncategorized
2023-10-23
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2023-10-23 07:33:222024-11-08 11:31:41Pictures annual meeting 2023

Survey annual consortium meeting 20-09-2024

Uncategorized
2023-10-23
https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png 0 0 Susette Lauwen https://www.dare-nl.nl/wp-content/uploads/2022/12/DARE-NL-logo-300x151.png Susette Lauwen2023-09-07 10:08:052024-10-03 09:22:01Survey annual consortium meeting 20-09-2024
Page 1 of 212

Contact

For questions or comments related to DARE-NL or oncological ATMPs, to become a partner or connect for information

contact us at info@dare-nl.nl.

© DARE-NL

Scroll to top Scroll to top Scroll to top
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}